To recover your password please fill in your email address
Please fill in below form to create an account with us
A randomized trial of durvalumab and tremelimumab +/- platinum-based chemotherapy in patients with high-risk, metastatic (stage IV) squamous or non-squamous non-small cell lung cancer (NSCLC).
See ANZCTR for full trial details >
Canadian Cancer Trial Group (CCTG), Astra Zeneca
Patients with confirmed stage IV diagnosis of squamous or non-squamous, non-small cell carcinoma of the lung.
Australia & Canada
Australian lead group: